STAT+: Pharmalittle: We’re reading about AstraZeneca threatening the U.K., mpox vaccine distribution, and more
STAT
AUGUST 23, 2024
The comments came in response to an article The Financial Times that claimed the company is considered changing the location of a $578 million vaccine manufacturing plant from Liverpool to Philadelphia because the new U.K. and Japan, and have been in widespread use for mpox since 2022.
Let's personalize your content